The endothelium and atrial fibrillation. The prothrombotic state revisited

B Freestone1, G Y H Lip

  • 1Haemostasis, Thrombosis, and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, Great Britain.

Hamostaseologie
|October 7, 2008
PubMed

Insights

Atrial fibrillation (AF) increases stroke risk by promoting blood clots. This review explores how blood components like platelets, coagulation factors, and inflammation contribute to this prothrombotic state in AF patients.

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Biology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia linked to high stroke and thromboembolism risk.
  • The exact mechanisms driving AF-related thromboembolism require further elucidation.
  • AF aligns with Virchow's triad, involving abnormal blood flow, vessel wall issues, and altered blood constituents.

Purpose of the Study:

  • To review current evidence on the prothrombotic state in AF.
  • To focus on the roles of coagulation, fibrinolysis, platelets, and inflammation.
  • To specifically examine the interplay between the endothelium and AF.

Main Methods:

  • Literature review of existing research on AF and thrombogenesis.
  • Analysis of studies investigating coagulation and fibrinolytic pathways.
  • Examination of research on platelet activation and inflammatory markers in AF.

Main Results:

  • AF is associated with altered flow dynamics, loss of atrial contractility, and irregular cardiac output.
  • Endocardial damage and structural heart disease contribute to the prothrombotic state.
  • Abnormalities in platelet function, coagulation factors, fibrinolytic components, and inflammation are implicated in AF-related thrombosis.

Conclusions:

  • AF creates a prothrombotic environment through a combination of hemodynamic, structural, and blood constituent abnormalities.
  • Coagulation, fibrinolysis, platelets, and inflammation are key factors in AF-associated thromboembolism.
  • Understanding the role of the endothelium in AF is crucial for developing targeted therapies.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...